These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6352237)

  • 21. [Effects of guanabenz on the cardiovascular system, in comparison with clonidine and guanethidine].
    Hojo M; Yoshida Y; Nagasaka Y; Machida K; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):39-58. PubMed ID: 6852681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of placebo versus guanabenz on hypertensive out-patients.
    Walker BR; Schneider BE; Rudnick MR; Gold JA
    J Int Med Res; 1980; 8(5):303-13. PubMed ID: 7418949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of CNS sympatho-inhibition produced by guanabenz.
    Koss MC
    Eur J Pharmacol; 1983 May; 90(1):19-27. PubMed ID: 6873176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in dogs: comparison of phenylephrine, clonidine, and guanabenz.
    Wolff DW; Buckalew VM; Strandhoy JW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S793-8. PubMed ID: 6084127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of guanabenz therapy on renal function and body fluid composition.
    Bauer JH
    Arch Intern Med; 1983 Jun; 143(6):1163-7. PubMed ID: 6860045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha 2-adrenoceptor agonists in the treatment of hypertension.
    Kaplan NM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S64-6. PubMed ID: 2417050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alpha-2 agonists on renal function in hypertensive humans.
    Goldberg M; Gehr M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S34-7. PubMed ID: 2417046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sinoatrial and atrioventricular dysfunction associated with the use of guanabenz acetate.
    LaRusso P; Jessup SA; Rogers FJ; Rogers JC
    Can J Cardiol; 1988 Apr; 4(3):146-8. PubMed ID: 3378199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of guanabenz on sodium and water homeostasis.
    Braden G; Alvis R; Walker BR; Cox M
    J Clin Hypertens; 1987 Dec; 3(4):397-404. PubMed ID: 3453382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of centrally acting antihypertensive drugs on the renin-angiotensin system and vasopressin.
    Waeber B; Nussberger J; Brunner HR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S799-802. PubMed ID: 6084128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic and water diuretic effects of central alpha 2-adrenoceptor agonists.
    Gehr M; MacCarthy EP; Goldberg M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S781-6. PubMed ID: 6084125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements.
    Hashimoto J; Chonan K; Aoki Y; Ugajin T; Yamaguchi J; Nishimura T; Kikuya M; Michimata M; Matsubara M; Araki T; Hozawa A; Ohkubo T; Imai Y
    J Hypertens; 2003 Apr; 21(4):805-11. PubMed ID: 12658028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of guanabenz, alpha 2 central agonist, on the activity of the sympathetic nervous system during dynamic and isometric physical exercise].
    Fariello R; Agabiti-Rosei E; Alicandri C; Romanelli G; Muiesan G; Renzetti I
    Minerva Cardioangiol; 1984 May; 32(5):273-9. PubMed ID: 6382054
    [No Abstract]   [Full Text] [Related]  

  • 36. Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic.
    McCarron DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S853-8. PubMed ID: 6084139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system-renal interrelationship in mechanism of action of guanabenz: role of peripheral alpha 2-adrenoceptor agonist activity.
    DiBona GF
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S543-4. PubMed ID: 6208425
    [No Abstract]   [Full Text] [Related]  

  • 38. Centrally acting antihypertensive agents: an update.
    Sica DA
    J Clin Hypertens (Greenwich); 2007 May; 9(5):399-405. PubMed ID: 17485976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological studies of guanabenz: effects of the central nervous system].
    Ohata K; Murata T; Sakamoto H; Inoue K; Kobayashi M; Kohno S; Nagasaka Y; Kasai H
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):471-80. PubMed ID: 7160794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanabenz: a centrally acting, natriuretic antihypertensive drug.
    Gehr M; MacCarthy EP; Goldberg M
    Kidney Int; 1986 Jun; 29(6):1203-8. PubMed ID: 3528613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.